|
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original work, preferably brief reports, in the fields of Gynecology,
Obstetrics, Fetal Medicine, Gynecological Endocrinology and related subjects.
(Fertility and Sterility, Menopause, Uro-gynecology, Ultrasound in Obstetrics
and Gynecology, Sexually Transmitted Diseases).The Journal is covered by INDEX
MEDICUS, MEDLINE, EMBASE/Excerpta Medica.
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY is issued every three
months in one volume per year by IROG CANADA Inc. Montréal. Printed in Italy by
"La Garangola", Tipografia Editrice - Via E. Dalla Costa, 6 -35129 Padova
(Italy).
Clinical and Experimental Obstetrics and
Gynecology
http://www.irog.net/
General Information
CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY (ISSN 0390-6663) publishes
original peer-reviewed work, preferably brief reports, in the fields of
Gynecology, Obstetrics, Fetal Medicine, Gynecological Endocrinology, Fertility
and Sterility, Menopause, Uro-gynecology, Ultrasound diagnosis in Obstetrics
and Gynecology, Sexually transmitted diseases and related topics. It is indexed
in INDEX MEDICUS, MEDLINE, EMBASE/ Excerpta Medica.
AIMS AND SCOPE
Since its inception, the CLINICAL AND EXPERIMENTAL OBSTETRICS AND GYNECOLOGY
Journal has had the primary aim to assemble and diffuse scientific
researches, particularly original researches, contributions, reviews, and
proceedings of meetings in every field of the Discipline.
Today its large diffusion all over the world allows us to collect high quality
papers and clinical reports on many interesting studies from every country,
even from developing countries. This is the target goal of the Journal –
aiming at the diffusion of knowledge and advances in female genital diseases.
This publication tries to cover all aspects of obstetrics and gynecology in an
interdisciplinary approach among gynecologists, epidemiologists, pathologists,
oncologists, radiologists, microbiologists, surgeons, urologists,
neonatologists, genetists and so on.
The first target goal of the Journal is to publish high quality papers
in the shortest time possible. Research papers, editorial
reviews, case reports, technical notes, book reviews and letters to the Editor
are published.
ANNOUNCEMENTS regarding meetings,
postgraduate courses and symposia will be accepted 6 months before publication
and will be published free of charge.
BOOK SAMPLES for review should be sent to the
Editorial offices in Montréal or in Padova.
COPYRIGHT: the Journal has been registered with the
Copyright Clearance Center, Inc. Reproductions are not allowed without the
written consent of the Publisher. All photocopy fees should be paid to the
Copyright Clearance Center, Inc., 21 Congress Street, Salem, MA 01970, USA
stating the ISSN number, the volume and the first and last page numbers of each
article copied.
ADVERTISING INFORMATION: advertising orders and
inquiries may be sent to: I.R.O.G. CANADA Inc., Publisher, 4900 Côte St.
Luc, Apt. 212, Montréal (Quebec) Canada H3W 2HS, Tél.
514.4893242-4893640 - Fax 514.4854513 - E-mail:
canlux@mgroup-online.com - www.irog.net
RESPONSIBILITY: although every effort is made by the
editorial staff and the printer to eliminate misleading or inaccurate
information, the publisher accepts no responsibility for the consequences of
faultful or incorrect information. The authors recognize that the editor and
publisher have no responsibility and are indemnified against any liability or
claim that may result from the publication of misleading or incorrect data.
SUBSCRIPTION INFORMATION
The Journal is issued every three months (January, April, July and October);
one volume per year. Subscriptions start from January and are automatically
renewed if not cancelled by the end of September.
Subscriptions include four issues per year plus supplements and monographs and
all official communications of Meetings, Courses, Symposia and all scientific
activities in the fields of Obstetrics and Gynecology and related
topics.
Subscriptions are entered with prepayment only. The
annual subscription is $280 US for Institutions and $170 US for Individuals all
over the world. For air mail add $20. Single copies prepaid cost $75.00 US.
Send subscription requests with cheque or credit card payment (Amex - Visa -
Diners - Master Card) to I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt.
212, Montréal, Québec H3W 2H3, Canada. Only US Funds are
accepted.
Claims for missing issues can be honored up to six
months. Changes of address: allow six weeks for all
changes to become effective. All communications should include both old and new
addresses (with postal codes) - better if accompanied by a mailing label from a
recent issue and should be sent to the printer La Garangola, Via E. Dalla
Costa, 6 - 35129 Padova (Italy) - also by Tel. +39.049.8075557, Fax
+39.049.7806580. Claims should be made within six months of publication date.
Duplicate copies will not be sent to replace those undelivered through failure
to notify of change of address.
Single copies and back issue and volume information is
available from the printer La Garangola, Padua, Tel. +39.049.8075557, Fax
+39.049.7806580. Certain back issues may only be available as photocopies of
the originals.
All other business correspondence including orders for offprints and
advertising space and any communication and requests should be addressed to
I.R.O.G. CANADA Inc., 4900 Côte St. Luc, Apt. 212, MONTRÉAL,
QUÉBEC H3W 2H3 (Canada), Tel. (514) 4893242, fax (514) 4854513.
IN ALL LEGAL MATTERS THE COURT OF MONTREAL IS COMPETENT.
Instructions to Authors
SUBMISSION OF MANUSCRIPTS
Papers should be submitted to A. ONNIS Editor-in-Chief of the EUROPEAN JOURNAL
OF GYNAECOLOGICAL ONCOLOGY, 4900 Côte St. Luc, Apt. 212 MONTREAL, QUÉBEC H3W
2H3 (Canada) - Tel. +514-4893242 - Fax +514-4854513, or Galleria Sto-rione 2/A
- 35123 PADOVA (Italy) - Fax +39-049-8752018.
Editorial articles for publication in the "Distinguished Expert Series" should
be submitted to P. Bösze, Editor-in-Chief of this section, Department of
Gynecology, Saint Stephan Hospital, 1096 Budapest, Nagyvárad tér 1, Telephone
(36-1) 275 2172, Fax (36-1)
275 2172, E-mail: bosze@axelero.hu
When a manuscript is submitted, an acknowledgement card is sent to the
corresponding author within two or three weeks.
Submitted papers are reviewed by the Editor-in-Chief and his Peer Referees.
Authors may be required to modify the manuscript according to the reviewers'
suggestions.
Manuscripts accepted for publication will be copyedited by the editorial staff
for typographical and grammatical mistakes and to guarantee clarity and
conciseness.
Publication time will be the shortest possible based on
scientific and publishing needs. Manuscripts submitted for publi-cation
cannot be returned.
Published papers will become property of the Journal and copyrighted under
I.R.O.G. CANADA Inc.
After six months no grievances will be accepted regarding published articles.
All statements are the responsibility of the authors. Product dosages,
indications and methods referred to in the papers reflect the author's
experience. No responsibility is assumed by the Editor-in-Chief or the
Publisher for any damage from use of any products, operation methods or
instructions contained in the published materials.
Trade names, trademarks, etc. are protected by the law and regulations. The
Editor-in-Chief and the Publisher cannot accept any legal responsibility for
any errors or omissions that may be made in press, particularly for information
about drug dosage and appli-cation thereof contained in the Journal. Consult
the prescribing information before administering any drug.
MANUSCRIPT REQUIREMENTS
The Journal follows the "Uniform requirements for manuscripts submitted to
biomedical journals" published in the New England Journal of Medicine 1991,
324, 424-8 and in the British Medical Journal 1991, 302.
Three manuscripts, typed and double spaced should be submitted
with an electronic disk, formatted in Word for Macintosh or Windows, version
6.0. Manuscripts without an electronic disk will not be accepted.
A cover letter signed by all authors must state that all authors who have
participated in the work take responsibility for the manuscript which has never
been pub lished or submitted for publication elsewhere. Without a
cover letter the publication will not be possible. Name, address and phone/fax
numbers of the Corresponding Author, responsible for revision and approval of
the proofs, should be indicated. Full-length articles should not exceed 8
printed pages including tables and references.
After the title page (full title and names of authors,
institutions, eventual acknowledgement for financial support, running title of
no more than 60 characters or spaces), original works should be arranged in the
conventional order: Summary (purpose of investiga-tion, methods, results,
conclusion - about 150 words), Key words, Content (a 20-word
summary), Introduction, Materials and Methods, Results, Discussion,
Conclusion, Acknowledgement (if any), References, Tables, Legends.
Authors should supply a complete address for reprint requests.
In the text only standard abbreviations can be used and must be avoided in the
title. The full term for which an abbreviation stands should precede its first
use in the summary and text unless it is a standard unit of measurement.
Authors must give their complete professional identifications
and affiliations, including all academic titles and positions.
Letters to the editor should be brief (500 words or less) and
offer objective, constructive and educational criticism of published material.
The editor reserves the right to publish.
Figures: Two original copies (not negatives) of each figure
are requested. Each figure should have a label on the back indicating its
number, author's name and top of the figure. Do not write on the back of the
figures and do not mount them on cardboard. If sending colour pictures
advise if they must be printed in colour or black and white (colour costs ten
times more).
Legends should be typed on a separate page with Arabic
numerals corresponding to the illustrations.
Tables should be titled, typed in double space on separate
pages and numbered in Arabic numerals in the order of their first cita-tion
in the text. Do not use internal rules. Only standard, universally understood
abbreviations should be used.
References should be numbered consecutively in the order in which they are
first mentioned in the text. Identify references in the text,
tables, and legends by Arabic numerals in parentheses.
Use the style of the examples below, which are based with slight modifications
on the format used by the U.S. National Library of Medicine in Index Medicus.
The titles of journals should be abbreviated according to the style used in
Index Medicus.
References must be verified by the Author(s) against the original documents.
Examples of correct forms of references are given below:
Articles in Journals: Authors' surname and initials (if more
than six names, give six followed by "et al."), Title, Abbreviated Journal
Title, Year of Publication, Volume, Issue and first page.
Books: Authors' surname and initials, title of the book and
title of chapter, in: Title, Editor(s), Place, Publisher, Year, Page.
Acknowledgments will be limited to appropriate professionals who
were contributors to the paper.
PROOFS revised by the editorial staff will be sent
to the corresponding author and should be checked and returned within ten days.
The corresponding author is responsible for detecting typesetting errors. After
this deadline the proofs will be considered approved. Only essential
corrections should be made; extensive changes will be charged to the authors.
BUSINESS MATTERS
The Journal has no commercial advertisements.
Authors will be expected to contribute to the printing expenses, tables,
figures and postage. For every published article a copy of the
Journal will be provided free of charge. Only payments in US dollars will
be accepted. No bank transfers.
Reprints should be requested with the form enclosed with the
acceptance letter. No free reprints will be supplied.
© By I.R.O.G. CANADA INC. - Publisher - Editorial office 4900
Côte St. Luc - Apt. 212 - Montréal Québec H3W 2H3 (Canada) - Tel. (514)
4893242-4893640 -Fax (514) 4854513 - Printed in Italy by "La Garangola" - Via
E. Dalla Costa, 6 - 35129 Padua (Italy) - Responsible Director: Prof. Antonio
Onnis M.D. - Authorization of Padua's Court n. 633 - 28-6-1979
|
| |
 Clinical and Experimental Obstetrics & Gynecology - Vol. XXXIX, no. 1, 2012 |
| |
|
| EDITORIAL ARTICLES |
|
Physicians should be more open-minded about performing in vitro fertilization-embryo transfer in
women with diminished oocyte reserve and consider the couple’s wishes and desires |
5 |
J.H. Check - Camden, NJ (USA)
Pregnancies despite very diminished oocyte reserve are possible with IVF-ET and patient wishes should be heavily considered
in therapeutic decisions. |
|
|
|
| ORIGINAL ARTICLES |
|
| Reproductive Biology Section |
|
“Embryo glue” does not seem to improve chances of subsequent pregnancy in refractory in vitro
fertilization cases |
11 |
J.H. Check, D. Summers-Chase, W. Yuan, K. Swenson, D. Horwath, M. Press - Camden, NJ (USA)
A matched control study failed to demonstrate any benefit of using “embryo glue” to allow better implantation in refractory
IVF cases. |
|
Predicting ovarian reserve and reproductive outcome using antimüllerian hormone (AMH) and antral
follicle count (AFC) in patients with previous assisted reproduction technique (ART) failure |
13 |
F. Bonilla-Musoles, J.C. Castillo, O. Caballero, J. Pérez-Panades, F. Bonilla Jr., M. Dolz, N. Osborne -
Valencia, SPAIN
AMH levels and AFC are reliable indicators of ovarian reserve. Patients with ovarian reserve levels that predict a very low
probability of success should be informed about the poor prognosis. |
|
| Frequency of subnormal hypoosmotic swelling tests increase with advancing age of the male |
19 |
J.H. Check, D. Kramer, A. Bollendorf, C. Wilson - Camden, NJ (USA)
The frequency of subnormal hypoosmotic swelling tests doubles in males aged 45-45.9 and quadruples in males ≥ 50 vs ≤ 34. |
|
Intracytoplasmic sperm injection completely negates the implantation problem associated with
conventional fertilization with sperm with low hypoosmotic swelling test scores as evidenced by
evaluating donor-recipient pairs |
21 |
J.H. Check, B. Katsoff, W. Yuan, D. Summers-Chase, W. Hourani, D. Horwath - Camden, NJ (USA)
Evaluating matched pairs shows that ICSI overcomes the embryo implantation potential of embryos fertilized by sperm with
low HOS scores. |
|
Pregnancy outcome following fresh vs frozen embryo transfer into gestational carriers using a simplified
slow freeze protocol |
23 |
J.H. Check, B. Katsoff, C. Wilson, J.K. Choe, D. Brasile - Camden, NJ (USA)
Live delivered pregnancy rates are 50% higher with fresh vs frozen thawed embryo transfer into gestational carriers. |
|
| The majority of males with subnormal hypoosmotic test scores have normal vitality |
25 |
A. Bollendorf, J.H. Check, D. Kramer - Camden, NJ (USA)
Only 12.5% of males with low hypoosmotic swelling (HOS) tests have low vitality tests and thus they are not interchangeable. |
|
| General Section |
|
| Immune response and immunotherapy in intraepithelial and invasive lesions of the uterine cervix |
27 |
F.A. Machado, J.Ph. Janssens, M.A. Michelin, E.F.C. Murta - Uberaba, MG (BRAZIL)
Immunotherapy has the potential to be the most specific treatment for tumors including cervical intraepithelial neoplasia. |
|
Severe hepatocellular dysfunction in obstetric cholestasis related to combined genetic variation in
hepatobiliary transporters |
32 |
V. Zimmer, M. Krawczyk, M. Mahler, S.N. Weber, R. Müllenbach, F. Lammert - Homburg, GERMANY
An exceptional co-inheritance of three hepatobiliary transporter variants in ABCB4, ABCB11 and ABCG5/8 in obstetric
cholestasis is reported. |
|
The effects of benzoylecgonine, oxytocin, ritodrine and atosiban on the contractility of myometrium.
An experimental study |
36 |
N. Nikolettos, I. Triantafillidis, V. Karachaliou, G. Koutsougeras, I. Vakalopoulos - Thessaloniki, GREECE
The use of ritodrine seems to be preferable for the treatment of myometrial contractions induced by cocaine metabolites. |
|
Regulation of interleukin-1 and tumor necrosis factor- -induced interleukin-8 production by amnionderived
(WISH) cells |
43 |
Y. Kawano, Y. Furukawa, S. Karakida, N. Kira, T. Ishii, H. Narahara - Oita, JAPAN
IL-8 production regulated by cytokines in amniotic cells. |
|
The efficacy of paracetamol versus tenoxicam on postoperative pain and morphine consumption
after abdominal hysterectomy: a placebo-controlled, randomized study |
49 |
| I. Gunusen, S. Karaman, A. Acar, A. Sargin, V. Firat - Izmir, TURKEY
The analgesic effects of paracetamol and tenoxicam combined with morphine were compared after elective abdominal hysterectomy.
Tenoxicam provided reliable analgesia and reduced opioid-related side-effects. |
|
| Malignant disease as a risk factor for surgical site infection |
53 |
S. Kadija, A. Stefanovic´, K. Jeremic´, J. Tavcˇar, R. Argirovic´, S. Pantovic´ - Belgrade, SERBIA
A retrospective study demonstrated that advanced stages of malignant disease are important risk factors for SSI with a relative
risk of 4 and 5, respectively. |
|
| The trend of VEGF-A and PlGF in pregnant patients: a perspective case-control study on 214 women |
57 |
T.S. Patrelli, S. Gizzo, M. Plebani, D. Basso, G. Capobianco, C. Bartolucci, A. Bacchi Modena,
M. Rondinelli, G.B. Nardelli - Parma, ITALY
Vascular growth factors: a new role for VEGF-A and PIGF in Clinical Obstetrics? |
|
Immunohistochemical changes of adenomyosis after heat therapy: comparison of radiofrequency
myolysis and endoablation |
65 |
H.H. Cho, Y.H. Song, M.R. Kim, S.J. Hwang, J.H. Kim - Seoul, KOREA REPUBLIC
Direct heat therapy is more effective than endometrial ablation in adenomyosis. |
|
| Risk factors and prevalence of urinary incontinence in postmenopausal women living in Turkey |
69 |
S. Senturk, M. Kara - Yozgat, TURKEY
BMI, parity, vaginal delivery, advanced age and non use of HRT were detected as significant risk factors for women. |
|
| Comparison of propofol/ketamine versus propofol/alfentanil for dilatation and curettage |
72 |
L. Sahin, M. Sahin, O. Aktas, E. Kilic, E. Mandollu - Kahramanmaras, TURKEY
Clinical efficacy of ketamine and alfentanil when combined with propofol for short-lasting anesthesia during D&C. |
|
| Removal of uterine fibroids during cesarean section: a difficult therapeutic decision |
76 |
Y. Simsek, S. Celen, N. Danisman, L. Mollamahmutog˘lu - Ankara, TURKEY
Effects of myoma excision performed during cesarean operation on obstetrical outcome were analyzed in a controlled fashion. |
|
| The impact of HPV diagnosis on women’s sexual and mental health: preliminary findings |
79 |
F. Ferenidou, N. Salakos, N. Vaidakis, G. Paltoglou, K. Bakalianou, G. Papadimitriou, G. Creatsas - Athens,
GREECE
HPV diagnosis has an important impact on emotional and physical well being, as well as psychosexual health of women. |
|
Magnetic resonance hysterosalpingography in the evaluation of tubal patency in infertile women: an
observational study |
83 |
C. De Felice, F. Rech, A. Marini, A. Stagnitti, F. Valente, V. Cipolla, G. Borgogni, M.L. Meggiorini - Rome, ITALY
The ability of magnetic resonance hysterosalpingography (MR-HSG) to demonstrate fallopian tube patency in infertile women. |
|
Effects of methylene blue, pentoxyphylline and enoxaparin on postoperative adhesion formation and
markers of angiogenesis in a rat uterine horn model |
89 |
A. Boztosun, A. Pıçak, M.I. Kosar, S. Gulturk, A. Cetin - Sivas, TURKEY
Methylene blue may prevent postoperative adhesions by the inhibition of angiogenesis. |
|
| Molecular diagnosis of CMV infection in fetal aborted tissues in the region of Thrace |
96 |
I. Grammatikopoulou, M. Lambropoulou, E. Chatzaki, T.-E. Deftereou, V. Lambropoulou, M. Simopoulou,
E. Papadopoulos, G. Galazios, Th. Dimitriou, A. Petrou, N. Papadopoulos - Alexandroupolis, GREECE
The molecular study of CMV infection in 143 fetal aborted tissues, indicated a 1.4% incidence. |
|
Examination of the effect of melatonin use in Pomeroy method of tubal ligation on ovarian histology
in rats |
103 |
A.Ç. Altungül, A. Kale, E. Sapmaz, N. Akpolat - Malatya, TURKEY
The left pomeroy method of tubal ligation reduces regression of angiogenesis in the corpus luteum, and increases atretic follicle
and fibrosis development. Melatonin use can restore these harmful effects. |
|
Effect of fibrin glue and comparison with suture on experimental induction of endometriosis in a rat
endometrial autograft model |
107 |
A. Boztosun, H. Özer, R. Atılgan, G. Açmaz, T. Yalta, I · .I·. Müderris, A. Yanık - Malatya, TURKEY
Endometriosis-like lesions can be obtained by FG in animal models. |
|
| Comparison of diclofenac sodium with indomethacin suppositories for mediolateral episiotomies |
112 |
A.Ç. Altungül, E. Sapmaz, A. Kale - Adana, TURKEY
Diclophenac sodium suppositories have more effective analgesia than indomethacin suppositories after mediolateral episiotomies
in early and late terms. |
|
CASE REPORTS |
|
Early abdominal pregnancy with an unexpected and misleading location. The ultrasonographic
interpretation |
115 |
M. Simões, C. Marques, F. Ribeiro, C. Guerreiro, I. Grilo, D. Rosa - Lisboa, PORTUGAL
A case of an early primary implantation abdominal pregnancy with a misleading and unexpected location is described. |
|
First trimester diagnosis of 13q-syndrome associated with increased fetal nuchal translucency thickness.
Clinical findings and systematic review |
118 |
E. Manolakos, P. Peitsidis, A. Garas, A. Vetro, M. Eleftheriades, M.B. Petersen, I. Papoulidis - Athens,
GREECE
Diagnosis of 13q-syndrome demonstred that CGH-arry is a precise diagnostic tool which can complete with traditional methods
for prenatal chromosomal detection. |
|
| Complicated abdominal hysterectomy subsequent to uterine embolization for large fibroids |
122 |
I. Korkontzelos, N. Gkioulekas, C. Stamatopoulos, A. Magos - London, UK
A case of a complicated hysterectomy due to strong adhesions found intraabdominally most probably created by tissue necrosis
of the fibroids after UAE. |
|
Removal of a large bizarre uterine leiomyoma by operative hysteroscopy. Case report and review of the
literature |
124 |
O. Gregoriou, C. Grigoriadis, V.E. Hatzidakis, S. Mantzavinos, A. Kondi-Pafiti - Athens, GREECE
Study of a case of bizarre uterine leiomyoma removed by operative hysteroscopy and literature review. |
|
| Pancreatic cancer with liver metastases in a pregnant patient: case report and review of the literature |
127 |
R. Marci, G. Pansini, C. Zavatta, E. Mossuto, E. Giugliano, M. Marzola, A. Patella - Ferrara, ITALY
Case of malignant pancreatic tumor in pregnancy is reffered. |
|
| Huge endometriosis presenting like an ovarian tumor: CT appearance |
237 |
H. Yerli, N. Askar, O. Zekioglu, Z. Baglan, N. Elmas - Izmir, TURKEY
The problematic differential diagnosis between endometriosis and ovarian tumor is discussed. |
|
| ERRATA - CORRIGE |
|
Infectious respiratory diseases in pregnancy - results of a 15-year study in Seoul
Joo Yeon Cheung, Sung Shine Shim, Yookyung Kim
Vol. XXXVIII, n. 4, 2011, page 351
Errata: Department of Radiology, Mokdong Hospital, Ewha Woman’s University School of Medicine, Seoul (Korea)
Corrige: Department of Radiology, Mokdong Hospital, Ewha Womans University School of Medicine, Seoul (Korea) |
|
| ERRATA - CORRIGE |
|
Evaluation of clinical and cytogenetic fındings on 1,068 second-trimester amniocenteses in Southeast Turkey
M. Balkan, H. Akbas, S. Kalkanli, M. Erdemog˘lu, M. Fidanboy, M.N. Alp, T. Budak
Vol. XXXVIII, n. 4, 2011, page 311
Errata: M. Balkan, H. Akbas, S. Kalkanli, M. Erdemog˘lu, M. Fidanboy, M.N. Alp, T. Budak
Corrige: M. Balkan, H. Akbas, S. Kalkanli, M.N. Sakar, M. Fidanboy, M.N. Alp, T. Budak |
|
|